Navigation Links
China-Biotics, Inc. Announces the Results of the 2010 Annual Meeting of Stockholders
Date:3/14/2011

SHANGHAI, March 14, 2011 /PRNewswire-Asia-FirstCall/ -- China-Biotics, Inc. (Nasdaq: CHBT) ("China-Biotics" or "the Company"), a leading developer, manufacturer and distributor of probiotics products in China, today announced the results of its 2010 Annual Meeting of Shareholders ("AGM") held on Wednesday, March 9, 2011 for stockholders of record of January 25, 2011, at the Company's Executive Offices at No. 26, Orient Global Headquarter, Lane 118 Yonghe Road, Zhabei District, Shanghai, P.R.China.

At the AGM, Mr. Song Jinan, the Chief Executive Officer and Chairman of the Board of China-Biotics, Dr. Chin Ji Wei, Dr. Du Wen Min and Mr. Simon Yick were elected by stockholders as directors of the Company until the 2011 Annual Meeting of Stockholders.

Stockholders ratified the appointment of BDO Limited as the Company's independent auditors for the fiscal year ending March 31, 2011.

Also at the AGM, stockholders adopted the Company's 2010 Equity Incentive Plan.

Stockholders approved by a non-binding vote the compensation of the Company's named executive officers.

Lastly, a proposal to hold an advisory vote on executive compensation every two years was approved by the shareholders.

China-Biotics' executives provided a brief report outlining the Company's past achievements, growth strategy and business outlook. Management responded to questions from shareholders.

"We are pleased with the results of the 2010 Annual Meeting of Shareholders," said Mr. Jinan Song, Chairman and CEO of China-Biotics, "Adoption of the equity incentive plan will benefit the Company and its shareholders by making it possible to attract and retain key talent. We appreciate our shareholders' support and will continue to create and enhance value as we move ahead with our growth plans and business development strategies."

About China-BioticsChina-Biotics, Inc. ("China-Biotics" or "the Company"), a leading manufacturer of biotechnology products and supplements, engages in the research, development, marketing and distribution of probiotics dietary supplements in China. Through its wholly owned subsidiaries, Shanghai Shining Biotechnology Co., Ltd. and Growing Bioengineering (Shanghai) Co. Ltd., the Company develops and produces a proprietary product portfolio. Currently, its retail products are sold over the counter, mainly through large distributors, to pharmacies and supermarkets in Beijing, Shanghai, and Jiangsu and Zhejiang provinces. The Company also sells bulk products to institutional customers such as dairy and animal feed producers as well as pharmaceutical companies. In February 2010, China-Biotics began its commercial production in China's largest probiotics production facility to meet the growing demand in China. For more information, please visit http://www.chn-biotics.com.Contact:Travis Cai Chief Financial OfficerChina-Biotics, Inc.traviscai@chn-biotics.comir@chn-biotics.comShiwei Yin/Dixon Chen Grayling646-284-9474shiwei.yin@grayling.comdixon.chen@grayling.com
'/>"/>

SOURCE China-Biotics, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. China-Biotics, Inc. Reports Record Quarterly Net Sales for the Third quarter of Fiscal Year 2011
2. China-Biotics, Inc. Comments on Market Rumors
3. China-Biotics, Inc. Announces US$20 million Share Buyback Program
4. China-Biotics, Inc. to Hold 2009 Annual Meeting of Stockholders on March 5, 2010
5. China-Biotics, Inc. Begins Trial Production at New Facility, Affirms 2010 Revenue Guidance
6. China-Biotics, Inc. Prices $69 Million Public Offering of Common Stock
7. Watson Announces Favorable District Court Ruling in Generic Fentora® Patent Suit
8. Biodel Announces Accelerated Development Plan for Ultra-Rapid-Acting Insulins: Initiate Phase 2 in 2011; Phase 3 Pivotal Trials in 2012
9. Nephros Announces Completion of Reverse Stock Split
10. Arena Pharmaceuticals Announces Fourth Quarter and Full Year 2010 Financial Results and Reviews Recent Developments
11. Nephros Announces Completion of $3.2 Million Financing Through Rights Offering and Private Placement Transactions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/8/2016)... , Feb. 8, 2016  Sangamo BioSciences, ... therapeutic genome editing, announced that the U.S. Food ... Investigational New Drug (IND) application for SB-318, a ... therapy for Mucopolysaccharidosis Type I (MPS I). The ... Sangamo to initiate a Phase 1/2 clinical study ...
(Date:2/8/2016)... February 8, 2016 ... published by Allied Market Research titled, "World ... Forecasts, 2014-2020", estimates the world synthetic biology market ... and sequencing technology segment would continue to lead ... tools segment, collectively, held around half of the ...
(Date:2/8/2016)... HOUSTON , 8. Februar 2016 /PRNewswire/ ... veröffentlichte heute eine Infografik mit dem Titel ... ganzen Welt), mit der der Krankheit gegenüber ... die dazu ermutigen soll, Medikamentenresistenz bei Epilepsie ... der allgemeinen Diskussion zu machen. Mithilfe der ...
Breaking Medicine Technology:
(Date:2/8/2016)... ... 08, 2016 , ... Stephanie Hebert Insurance Agency, serving families ... new charity campaign. As part of their ongoing community involvement program, funds are ... that children deserve a voice, and in the spirit of neighbors helping neighbors ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... expansion into Canada to provide its range of unique and advantaged protective ... Quebec City that will provide bilingual customer service and marketing support. A new ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... announced today that nominations will be accepted February 8, 2016 through May ... , Awards include the Information Security Executive® of the Year, which recognizes ...
(Date:2/8/2016)... ... February 08, 2016 , ... ... lower incidence rate of type 2 diabetes in the GrassrootsHealth cohort with substantially ... to make a change in public health,” states Carole Baggerly, Director of GrassrootsHealth, ...
(Date:2/8/2016)... , ... February 08, 2016 , ... The schedule ... in this country. The AutismOne 2016 Conference, which is being held May 25-29 at ... won’t hear elsewhere about helpful interventions and causes of chronic illness in children. , ...
Breaking Medicine News(10 mins):